Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4^CRBN Protein Degradation Axis

Cereblon (CRBN), a primary target of immune-modulatory imide drugs (IMiDs), functions as a substrate receptor in the CUL4-RBX1-DDB1-CRBN (known as CRL4^CRBN) E3 ubiquitin ligase complex. Binding of IMiDs to CRBN redirects the CRL4^CRBN E3 ubiquitin ligase to recruit or displace i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Seung-Joo Yang, Seungje Jeon, Jeong Won Baek, Kwang Min Lee, Chul-Seung Park
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-05-01
Colecção:	Pharmaceuticals
Assuntos:	thalidomide AMP-activated protein kinase cereblon
Acesso em linha:	https://www.mdpi.com/1424-8247/14/6/512
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!